The latest from DTC Perspectives

DTC Down Under

Friday, 09 October 2009, 08:03 AM

I read an interesting column on 10/7 from an Australian web site called crikey.com. It is very critical of the Australian health ministry for not cracking down on unbranded disease education ads sponsored by drug companies. The column bemoans the fact that Australian citizens are being bombarded with these ads and somehow drug companies are using loopholes to get away with it.

The Australian code allows disease education ads so no one is getting away with it. The author, Dr. Agnes Vitry does not like the fact that new medicines are more likely to be withdrawn as side effects unseen in clinical studies are discovered. Therefore she favors limiting information on new drugs, even for unbranded company sponsored disease education ads which she calls de facto DTC.

The same complaints have been heard in Canada and Europe for years. Somehow, Dr. Vitry sees a threat to public health by drug companies being allowed to advertise help seeking ads. The reality is that no government has been successful banning health information since the advent of the Internet. Unless governments take the North Korean approach and forbid the flow of any information from other countries, the information will be freely available on the Internet. There is no research that shows consumer awareness of new drugs is a public health concern.

Canada is failing in trying to pretend the U.S. media does not exist. Obviously Canadians are seeing U.S. ads through media spill and free availability of U.S. magazines and newspapers. The Canadian, European and Australian governments have a right to forbid branded or unbranded DTC. Clearly they have an interest in encouraging use of and providing low cost generics to their populace under their government assisted health plans. What is apparent is information does get through easily on branded drugs via the web. Citizens with certain conditions or diseases who want to know the latest drugs easily get that information from U.S. web sites.

The Europeans are still debating how much information to allow. Canadian DTC critics are calling for more enforcement of media spill with forbidden ads. Their attempts will fail, however, and their citizens have and will have access to drug ads at will. Yes, de facto DTC is in every country with Internet access. Putting the genie back in the bottle will not work. I am afraid the rest of the world will fall victim to unfettered health information from the U.S. whether they like it or not. Regulations prohibiting what citizens see on paper is irrelevant in the digital age.

Related articles

eHealth consumer analysis / pharma case studies at 'Reform & Refocus' Conference

From Manhattan Research's Cybercitizen Health v9.0 study, released this week:

Your Perspective Please

I have written 376 columns in the past 9 years giving my DTC perspective. I am now asking DTC marketers for their perspective in a short but important survey of plans,

J&J’s Group Product Director to Address Changing Media Landscape – DTC Reform & Refocus, Oct 14 – 15

Haya F. Taitel, Group Product Director, Johnson & Johnson and Nan-Kirsten Forte, Editor in Chief, WebMD the Magazine Join Faculty of Reform & Refocus Conference,

Doctors Group Calls for DTC Moratorium

The American College of Physicians (ACP) has issued a policy paper with six recommendations about how the FDA can improve its ability to approve and monitor new drugs.

The Health Care Advertising Dilemma

As Congress considers reining in health care costs, the issue of advertising is usually on the radar as a cost driver. I have written numerous times that the impact of

Read all related articles

DTC and You

The DTC National Conference

Register Now for The DTC National Conference 
April 7-9, 2010, Washington DC. The Formum for DTC 
Thought Leaders

 FREE Subscription to our Magazine
Start a free subscription now to the industry's leading
publication focused soley on DTC marketing,
 DTC Perspectives Magazine is published quarterly.

Subscribe to DTC Insights

The DTC Marketer's Executive Brief - DTC INSIGHTS
takes all the information and data pertinent to DTC
and analyzes it for a busy pharma marketer.

Subscribe to Bob Ehrlich’s newsletter

A weekly blog column from DTCPI CEO Bob Ehrlich
that reflects his observations on key trends affecting
our industry.

     Visit us on Facebook
DTC Perspectives, Inc is now on Facebook. Stay
Informed on the latest trends in the industry.


ABOUT SSL CERTIFICATES